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Insulin receptor partially purified from human placenta by chromatography on 
immobilized wheat germ agglutinin was subjected to affinity cross linking to determine 
the relationship between the subunit structure of the multiple forms of the insulin 
receptor and their competence to bind insulin and undergo autophosphorylation. It 
was demonstrated that, whereas the 340-kDa intact receptor undergoes autophos- 
phorylation, the 290- and 320-kDa insulin binding forms of the receptor do not. 
Phosphorylation at tyrosyl residues in the intact receptor was verified using a new 
facile method for determination of phosphorylated amino acids. The competence of 
the phosphorylated 340-kDa protein to bind insulin was demonstrated using a double- 
probe labeling protocol wherein receptor phosphorylated with [y-32P]ATP was cross- 
linked with disuccinimidyl suberate (DSS) in the presence of N’B29-biotinylinsulin. 
The observation that succinylavidin, by virtue of its interaction with biotinyl residues, 
decreased the electrophoretic mobility of receptor radiochemically labeled with 9 
indicated that the phosphorylated 340-kDa protein was competent to bind insulin. 
This result is compelling evidence that the 340~kDa phosphorylated species is insulin 
receptor itself, rather than a closely associated contaminant. Treatment of the 
receptor with the crosslinking agent DSS produced (after reduction and denaturation) 
a-dimer, P-dimer, and a smaller amount of tetramer. This observation is consistent 
with a symmetrical, tetrameric, a!fi2 structure for insulin receptor from human 
placenta, and excludes previously proposed alternative structures containing one (Y 
and one /3 chain. 0 1984 Academic Press, Inc. 
The structure and mode of action of 
insulin receptor have been discussed in 
recent reviews (1, 2). Structural studies 
of insulin receptor which had been labeled 
with affinity labels (3-5) or biosynthetic 
precursors (6-8) support the view that the 
receptor is a symmetrical tetrameric 
transmembrane glycoprotein, consisting 
of two insulin binding (Y subunits and two 
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/3 subunits. The p-subunits of the receptor 
have recently been discovered to undergo 
insulin-dependent phosphorylation (9,10). 
In vitro studies indicate that the /3 subunit 
of solubilized receptor is autophosphory- 
lated specifically at tyrosyl residues (9, 
11,12), and that this subunit also contains 
an ATP binding site (13,14). Additionally, 
solubilized receptor has been shown to 
catalyze insulin-dependent phosphoryla- 
tion of tyrosyl residues in exogenous sub- 
strates (11, 15, 16). Interestingly, several 
viral oncogene products (17) and growth 
factor receptors (18) also catalyze phos- 
phorylation of tyrosyl residues, suggesting 
that protein phosphorylation at tyrosyl 
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residues may be involved in the initiation 
of cellular proliferation in addition to 
triggering the cellular response to insulin. 
Determination of the linkage (if any) be- 
tween tyrosyl phosphorylation and the 
cellular response to insulin, however, is 
likely to require further characterization 
of the structure and interactions of the 
autophosphorylated insulin receptor. 
In this work results of affinity cross- 
linking and double-probe labeling studies 
are presented which support the symmet- 
rical a&$ structure proposed for the in- 
sulin receptor, and establish that only the 
intact form of the insulin receptor is 
competent to both bind insulin and un- 
dergo autophosphorylation. 
MATERIALS AND METHODS 
[r-SZP]ATP was obtained from ICN. Human anti- 
insulin receptor serum was generously provided by 
Dr. Kahn and Dr. White (of the Joslin Diabetes 
Center). 
Phosphor&t&m of insulin receptor. WGA’-purified 
receptor (10 pg), in 100 pl, was preincubated with 
106 nrd insulin in 25 mrd Hepes, pH 7.6,0.05% Triton 
X-100, 5 mrd MnCla for 1 h at room temperature, 
whereupon phosphorylation was initiated by addition 
of 10 pl 0.55 mM ATP, containing 5-20 pCi [y- 
82p]ATP. After the desired time period, the reaction 
was quenched by addition of twofold concentrated 
Laemmli sample buffer containing 50 mM DTT in- 
stead of @-mercaptoethanol, heated at 95°C for 3 
min, and subjected to SDS-PAGE (19). 
Crosslinking of phosphm&.ted insulin rece@or with 
insulin WGA-purified receptor, 20 pg in 200 ~1, was 
incubated with 100 nM insulin, with or without rzsI- 
insulin, in 25 mM Hepes, pH 7.6, 0.1 M NaCl, 0.1% 
BSA, 0.04% Triton, 5 mM MnCls at room temperature 
for 1 h. Phosphorylation was initiated by addition 
of 10 pl 1 mM ATP, with and without 5 &i [y- 
82p]ATP, to samples without and with =I-insulin, 
respectively. After 5 min at room temperature, the 
reaction mixture was cooled in an ice bath and the 
receptor was crosslinked by addition of 2 pl 30 mM 
’ Abbreviations used: DSS, disuccinimidyl subsrate; 
Me&SO, dimethyl sulfoxide; PTC, phenylthiocarbamyl; 
SDS, sodium dodecyl sulfate; SDS-PAGE, polyacryl- 
amide gel electrophoresis done in the presence of 
SDS; TEA, triethylamine; WGA, wheat germ agglu- 
tinin; Hepes 4-(2:hydroxyethyl)-1-piperazineethane 
sulfonic acid, BSA, bovine serum albumin; DTT, 
dithiothreitol; TPCK, L-1-p-tosylamino-2-phenyleth- 
ylchloromethyl ketone. 
DSS in Me&SO. After 45 min, the reaction mixture 
was quenched by addition of an equal volume of a 
twofold concentrated nonreducing sample buffer, 
heated at 95°C for 3 min, and subjected to SDS- 
PAGE. 
Crosslinking of phmphmylated insulin reoeptor with 
biotinylinsulin This procedure was similar to the 
one above, but with some modifications. The receptor 
was incubated with 5-100 nM Ng29-biotinylinsulin 
at 4°C for 15 h, and phosphorylated for 5 min at 
room temperature. The crosslinking reaction was 
quenched by addition of an equal volume of twofold 
concentrated nonreducing sample buffer, containing 
1.25% SDS (instead of 2%). Before being applied to 
the slab gel, 40 pl of sample was incubated with 10 
pl of 5 mg/ml succinylavidin at room temperature 
for 1 h. 
Pdga.oylumide gel elsctmphoresis SDS-PAGE was 
performed as described by Laemmli (19). Samples 
were heated for 3 min at 95°C in sample buffer with 
or without 25 mM DTI’. Usually, nonreduced samples 
were analyzed in 4.5% separation gels with acryl- 
amide:N,N’-methylenebisacrylamide in a ratio of 
30:0.3. Reduced samples were analyzed in 7.5% sep- 
aration gels with an acrylamide:N,Ar’-methylenebis- 
acrylamide ratio of 30:0.8. Normally, electrophoresis 
was performed at room temperature but, for samples 
treated with succinylavidin, it was at 4°C. After 
electrophoresis, the gel was stained, destained, soaked 
with 3% glycerol for 10 min, and finally air-dried in 
between two cellophane membranes (from Bio-Rad). 
The staining and destaining solutions were water: 
isopropanokacetic acid (330:120:5), with and without 
0.05% Coomassie blue, respectively. For autoradiog- 
raphy, Kodak X-Omat film was flashed before use 
(20), and a DuPont High-Speed Cronex X-ray screen 
was used for enhancement of detection. For following 
the time course of autophosphorylation of the recep- 
tor, the 95K radioactive band was excised from the 
dried gel using the autoradiogram to locate the 
band. After addition of 3 ml of aqueous counting 
scintillant (from Amersham). the radioactivity in 
the gel slices was measured in a Packard liquid 
scintillation spectrometer. Background radioactivity 
was measured in a gel slice of equal area above the 
95K band. For experiments which involved a second 
SDS-PAGE, the receptor bands were excised from 
the dried gel using the autoradiogram to locate the 
bands. The gel slices were further cut into smaller 
pieces and added into sample wells of the second 
slab gel. Finally, 50 pl sample buffer, with or without 
25 rnr4 DTT, was added. After 15 min of gel swelling, 
electrophoresis was started. 
Determination of the den&g of the p?wsph.o&&d 
aminoa& residuea The 95-kDa autophosphorylated 
species located after SDS-PAGE by autoradiography 
was cut out of the gel, and suspended with stirring 
in 2 ml 50 mM ammonium bicarbonate (pH 8.0) 
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containing 100 erg TPCK-treated trypsin (Worthing- 
ton). After stirring for 24 h at 37°C the supernatant 
solution was lyophilised. The resulting dried tryptic 
digest was transferred to a 6 X 50-mm test tube 
using the minimum amount of HpO to effect the 
transfer. Small-volume aliquots of unlabeled O- 
phosphoamino acid standards (50-100 nmol) and the 
internal standard a-aminobutyric acid (50-100 nmol) 
were added. After taking the contents of the 6 X 50- 
mm tube to dryness under reduced pressure, the 
tube was put in a 40-ml screw cap vial (Pierce No. 
13075) containing l-2 ml of double-distilled, constant- 
boiling HCl containing 0.1% phenol. The vial was 
flushed with nitrogen, capped (Pierce No. 13219) 
securely, and kept at 110°C for 1.5 h to effect 
hydrolysis by the HCl vapors. Phenylthiocarbamyl 
(PTC) derivatives of amino acids were prepared and 
analyzed using a modification of the general proce- 
dure for PTC-amino acid analysis by Koop et aL 
(21). 
After 1.5 h at llO’C, the small acidic residue in 
the 6 X 50-mm tube was taken to dryness under 
reduced pressure. Evaporation under reduced pres- 
sure was repeated after the following additions: 10 
pl Ha0 twice, 10 ~1 56 mM EDTA, and 10 ~1 TEA 
twice. The dried sample was mixed on a vortex 
mixer with 3 ~1 50% ethanol, and then mixed with 
10 ~1 of the PTC reaction mixture consisting of 90% 
ethanol:TEA:phenylisothiocyanate (7~21). The tube 
was covered and allowed to react for 10 min at room 
temperature. The reaction mixture was taken to 
dryness under reduced pressure. The residue was 
taken up in HPLC starting eluant (14% B) and 
centrifuged, and the supernatant solution was sub- 
jected to analysis by HPLC with a Varian 5000 
equipped with a Rheodyne injector using an Altex 
Ultrasphere ODS column (5 pm, 4.6 X 250 mm) at 
room temperature. The separation was achieved at 
constant flow rate (1.0 ml/min) with a two-eluant 
system, using the following elution program: Initial 
conditions, 14% B, at 10 min step to 22% B; at 13.5 
min step to 26% H, at 21.4 min step to 36% B; at 27 
min step to 100% B. Eluant A was 0.07 M phosphoric 
acid (Fischer, HPLC grade) adjusted to pH 6.8 with 
TEA, and eluant B was 100% acetonitrile (Fischer, 
HPLC grade). The detection of the PTC-amino acids 
was accomplished by monitoring absorbance at 254 
nm using a Model 450 variable-wavelength detector 
from Waters Associates. 82p activity was detected 
by mixing the 0.5-ml fractions, collected during 
HPLC, with 3.0 ml scintillation cocktail (ACS, 
Amersham), and counting the samples in a Packard 
liquid scintillation spectrometer. 
The sources of the other materials and the pro- 
tocols for the other methods used in this work have 
been described previously (22, 23). 
RESULTS AND DISCUSSION 
Figure 1 illustrates the insulin-mediated 
autophosphorylation that occurred when 
WGA-purified insulin receptor from hu- 
man placenta was incubated with [y- 
=P]ATP. The autoradiogram upon SDS- 
PAGE of the reduced labeled receptor 
revealed specific labeling of the 95kDa 
species which corresponds to the mass of 
the B subunit of the insulin receptor. 
Consistent with the view that the phos- 
phorylated 95kDa species is an integral 
part of the insulin receptor, addition of 
antireceptor antibody after phosphoryla- 
tion produced a precipitate which, upon 
4!5K* 
FIG. 1. Insulin-dependent phosphorylation of WGA- 
purified receptor. WGA-purified receptor (10 pg in 
100 ~1) was preincubated with (+) and without (-) 
106 nre insulin at room temperature for 1 h. [r- 
82plATP was then added, and phosphorylation was 
allowed to proceed for 3.5 min. The subsequent steps 
of SDS-PAGE (7.5% acrylamide) and autoradiog- 
raphy were carried out as described under Materials 
and Methods. Shown is an autoradiogram of a dried 
gel. The positions of molecular weight markers are 
shown on the left (myosin, 265 kDa; @-galactosidase, 
116 kDa; phosphorylase b, 94 kDa; bovine albumin, 
66 kDa; ovalbumin, 45 kDa). 
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reduction with DTT in the presence of 
SDS followed by SDS-PAGE and auto- 
radiography, showed the 95kDa band, 
whereas similar treatment of the super- 
natant solution from the immunoprecipi- 
tate revealed only a trace of the 95kDa 
band. The phosphorylated amino acid in 
the 95kDa species was found to be pri- 
marily phosphotyrosine by subjecting the 
excised section of the gel containing the 
95-kDa band to digestion with trypsin 
followed by limited acid hydrolysis of the 
solubilized peptides. Phosphoamino acids 
were separated and quantified by HPLC 
on a Cl8 column after they had been 
converted to PTC derivatives by reaction 
with Edman’s reagent (Fig. 2). These ob- 





FIG. 2. HPLC elution profile of the absorbance 
(solid line) for a mixture of phenylthiocarbamyl 
derivatives of phosphoamino acids (62.5 nmol each) 
and of cu-aminobutyrate (cuAB, 50 nmol). The mixture 
had been acid hydrolyzed and derivatized as described 
under Materials and Methods. The dashed line is 
the elution profile of cpm (for 0.5-ml fractions, X) 
collected upon chromatography of the mixture of 
phosphoamino acids obtained from limited hydrolysis 
of the 95-kDa phosphorylated moiety as described 
under Materials and Methods. &r(P), Thr(P), Tyr(P), 
cuAB, and Tyr are the elution positions of the phen- 
ylthiocarbamyl derivatives of a standard. Tyrosine 
was generated from phosphotyrosine during the acid 
hydrolysis (6 N HCl, 110°C for 1.5 h). The corre- 
sponding absorbance profile (not shown) for the 
sample from the 95-kDa band had many peaks due 
to other amino acids and incompletely hydrolyzed 
tryptic peptides. The initial part of the chromato- 
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FIG. 3. Time course of insulin-dependent auto- 
phosphorylation of insulin receptor. WGA-purified 
receptor (10 pg in 100 ~1) was phosphorylated at 
various concentrations of [Y-~)ATP (0, 25 GM; A, 
50 PM; 0, 100 PM). Phosphorylation was terminated 
at the time indicated on the z axis by heating the 
samples with D’IT-containing Laemmli sample buffer 
for 3 min. Proteins were separated by SDS-PAGE. 
The 95-kDa subunit of insulin receptor was excised 
from the dried gel, and ita radioactivity was mea- 
sured. Shown is the insulin-dependent incorporation 
of phosphate into this subunit, after subtracting 
insulin-independent incorporation. 
servations of insulin-mediated phosphor- 
ylation of the receptor with the WGA- 
purified receptor are essentially the same 
as those recently reported by Shia and 
Pilch (14), using receptor from human 
placenta which had been partially purified 
by chromatography on hydroxylapatite 
and DEAE-trisacryl. 
The time course of the insulin-depen- 
dent phosphorylation of the receptor is 
shown in Fig. 3 at several concentrations 
of ATP. The time dependencies illustrated 
in Fig. 3 indicate that, under the condi- 
tions used, phosphorylation was 50% com- 
plete within 2 min. The dependence of the 
steady-state level of phosphorylated re- 
ceptor on the ATP concentration is con- 
sistent with either the presence of a phos- 
phatase, which catalyzes dephosphoryla- 
tion of the receptor at a rate comparable 
to its rate of formation from ATP (at low 
ATP concentrations), or a low equilibrium 
constant for the formation of phosphory- 
lated receptor. 
To determine the relationship between 
phosphorylation and the binding of insu- 
lin, receptor was treated with the amine- 
specific crosslinking agent disuccinimidyl 
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FIG. 4. Crosslinking of phosphorylated receptor. (A) WGA-purified receptor (20 clg in 200 ~1) 
was incubated with 1.8 nM iP61-NgZB-biotinylinsulin (A, B), 100 nab insulin (B, D), 100 nM N-- 
biotinylinsulin (C), and without insulin (E) for 15 h at 4°C. Phosphorylation was carried out in 
50 PM ATP in the absence (A, B) and presence (C, D, E) of [-y-8ZpjATP at room temperature for 5 
min. The samples were then crosslinked with 0.3 rnlld DSS in ice for 45 min. After denaturation 
with nonreducing sample buffers, and with (+) and without (-) treatment of succinylavidin, the 
samples were analyzed in SDS-PAGE, 4.5% gel (acrylamide:methylenebisacrylamide, 100~1). The 
molecular weight markers were myosin (205 kDa), 6-galactosidase (116 kDa), and phosphorylase 
b (94 kDa). Samples A and B and samples C-E were run in the same gel, but autoradiographed 
for different time periods. (B) Phosphorylation was initiated after 1 h preincubation without 
(1,2) and with 106 nrd insulin at room temperature. After phosphorylation for 5 min, the samples 
were placed on ice for 45 min in the absence (1, 3) and presence (2, 4) of 0.3 rnrd DSS. After 
denaturation with nonreducing sample buffer, the samples were analyzed in SDS-PAGE, 
4.5% gel. 
suberate (DSS) in the presence of both 
ATP and insulin, or an insulin derivative, 
under the conditions used for phosphory- 
lation wherein either the ATP was labeled 
in the y position with 3aP or the insulin 
was labeled with lar’l. The autoradiogram 
in Fig. 4A (experiment A) reveals the 
labeling of the 340-, 320-, and 2%kDa 
species5 usually obtained when insulin re- 
ceptor was crosslinked in the presence of 
‘Y-insulin, and subjected to SDS-PAGE 
‘The molecular masses reported in this work are 
only nominal values deduced from the mobilities of 
protein standards. The nominal values obtained for 
the molecular weights for the three forms of the 
insulin receptor correspond to previously reported 
values (see Ref. (24)). 
without reduction. In experiments A-C 
presented in Fig. 4A, N’=-biotinylinsulin 
was used rather than insulin. The same 
labeling pattern as that shown in the (-) 
lane of experiment A for 1251-N’B29-biotin- 
ylinsulin was obtained with ‘%I-insulin. 
The specificity of the affinity crosslinking 
reaction is illustrated in experiment B, 
wherein the presence of excess unlabeled 
insulin diminished the crosslinking of ‘%I- 
WBa-biotinylinsulin to the receptor. 
As illustrated by the (-) lane of exper- 
iment C of Fig. 4A, there was a pro- 
nounced change in the autoradiogram 
when the labeled moiety was changed so 
that the radiochemical label was in the 
ATP rather than in the biotinylinsulin. 
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The autoradiogram for experiment C sug- 
gests that phosphorylation occurs pri- 
marily in a species with an apparent 
molecular mass of 340 kDa. The autora- 
diograms displayed in lanes 3 and 4 of 
Fig. 4B reveal that treatment with the 
crosslinking agent (DSS) results in a con- 
siderable increase in bandwidth. Thus, 
the crosslinking process rather than re- 
ceptor heterogeneity is the primary cause 
of the broad band in experiment C of Fig. 
4A. Inspection of Fig. 4B also reveals an 
increased mobility when the phosphory- 
lated receptor is crosslinked. This increase 
in mobility is attributed to a more compact 
structure for the crosslinked receptor, 
whose resistance to unfolding in SDS 
should be a function of its extent of cross- 
linking. The increase in band width caused 
by the crosslinking process, therefore, 
might well reflect production of receptor 
populations which differ with respect to 
their extent of crosslinking and electro- 
phoretic mobility. The broadness of the 
band and the level of phosphorylation was 
unchanged when insulin was substituted 
for WBB -biotinylinsulin (compare the (-) 
lanes of experiments C and D in Fig. 4A). 
Additionally, a much reduced level of 
phosphorylation was seen in the absence 
of insulin (experiment E in Fig. 4A and 
lanes 1 and 2 in Fig. 4B). A plausible 
explanation for the labeling of a single 
band with [y-32P]ATP is that only the 
340-kDa insulin-binding form of the re- 
ceptor undergoes autophosphorylation. 
It is well established that insulin recep- 
tor as obtained from various sources is 
heterogeneous with respect to molecular 
weight. Massague et al. (24) attribute this 
heterogeneity to limited proteolysis of the 
/3 subunit to a fll subunit, which gives rise 
to a mixture of a&J, a&3&, and intact 
CQ& tetramers. Shia and Pilch (14) have 
also observed that phosphorylation fol- 
lowed by SDS-PAGE under nonreducing 
conditions yields a single phosphorylated 
band which has the same electrophoretic 
mobility as the intact (~&a tetramer, and 
have concluded that only intact tetramer 
is autophosphorylated. This observation, 
however, does not unambiguously estab- 
lish that the high-molecular-weight form 
of the insulin receptor is phosphorylated, 
since phosphorylation could have de- 
creased the electrophoretic mobility of a 
low-molecular-weight form of the receptor 
to that of the intact receptor. This possi- 
bility was excluded by the observation 
that longer exposure of the autoradiogram 
for experiment B of Fig. 4A yields the 
290-, 320-, and 340-kDa bands in the same 
relative intensities as they appear in ex- 
periment A of Fig. 4A. The conditions 
used to study insulin binding in experi- 
ment B were similar to those used to 
study phosphorylation in experiments C 
and D, with the exception that in one set 
of experiments the radiochemically labeled 
species was insulin, whereas in the other 
set it was ATP. Thus, if phosphorylation 
produced a change in the electrophoretic 
mobility of the 320- or 290-kDa forms of 
the receptor, bands corresponding to those 
forms should have been absent when the 
insulin contained the label. 
The fact that only a minor population 
of the receptor appears to be phosphory- 
lated makes it important to verify that 
insulin receptor was phosphorylated rather 
than a closely associated contaminant. 
Although the observation that antibodies 
to the insulin receptor precipitate the 
phosphorylated 340~kDa protein provides 
strong evidence that insulin receptor is 
phosphorylated, the possibility has not 
been excluded that the phosphorylated 
protein represents a 340~kDa contaminant 
which is closely associated with the recep- 
tor. This possibility was excluded by dem- 
onstrating that the molecules which were 
phosphorylated were also competent to 
bind insulin. To do this a double-probe 
labeling protocol was used wherein the 
first probe was a 32P-labeled phosphoryl 
group and the second probe was WBm- 
biotinylinsulin.6 If insulin receptor mole- 
cules retained their competence to bind 
insulin after phosphorylation, they should 
6 It is important to note that studies of the capacity 
of a phosphorylated receptor preparation to bind 
insulin will not reveal the competence of the phos- 
phorylated protein to bind insulin, since this protein 
represents a minor population of the insulin binding 
proteins in the preparation. 
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become covalently bound to both 32P and 
N ‘B29-biotinylinsulin upon affinity cross- 
linking. Such q-labeled molecules should 
exhibit an increased molecular weight and 
decreased electrophoretic mobility upon 
treatment with succinylavidin prior to 
electrophoresis. The ability of succinylav- 
idin to decrease the electrophoretic mo- 
bility during SDS-PAGE of receptor 
linked to iVm-biotinylinsulin has been 
previously reported (22, 23), and is illus- 
trated in experiment A of Fig. 4A (com- 
pare (-) and (+) lanes which indicate 
treatment without (-) and with (+) suc- 
cinylavidin). The observation that treat- 
ment with succinylavidin decreases the 
electrophoretic mobility of the 340-kDa 
phosphorylated species (compare (-) and 
(+) lanes of experiment C, Fig. 4A) proves 
that the phosphorylated receptor is com- 
petent to bind insulin. The control, exper- 
iment D, shows that the succinylavidin 
treatment has no effect on the electropho- 
retie mobility of insulin receptor cross- 
linked in the presence of native insulin 
rather than biotinylinsulin. Examination 
of the autoradiogram in experiment C 
with a scanning densitometer indicated 
that, prior to treatment with succinylav- 
idin, there appears to be one broad peak 
which could be represented by a single 
Gaussian function but that treatment with 
succinylavidin resulted in the appearance 
of two overlapping peaks. The fraction of 
each component was determined with the 
aid of a computer program which fit the 
dependence of density on distance to the 
sum of two Gaussians. One of the com- 
ponents was assumed to be crosslinked 
receptor which did not become covalently 
linked to N’B29-biotinylinsulin and which 
therefore did not interact with the succi- 
nylavidin. The values for the standard 
deviation and the peak position for the 
component which did not interact with 
succinylavidin was assumed to be the same 
as those observed for the single peak 
obtained in the absence of succinylavidin. 
The fraction of each component indicated 
that only about 60% of the phosphorylated 
receptor was crosslinked to the biotinylin- 
sulin probe, when the concentration of 
this probe was 100 nM. Crosslinking effi- 
ciencies of 42-48s were observed at con- 
centrations of 5, 10, and 40 nM WBB- 
biotinylinsulin. These crosslinking effi- 
ciencies are within experimental error of 
the average value of 52% we obtained for 
the crosslinking efficiency for this probe 
when it binds to receptor in the absence 
of ATP (23). The correspondence between 
these efficiencies indicates that essentially 
all of the phosphorylated receptor mole- 
cules are bound to at least one molecule 
of insulin probe at insulin concentrations 
25 nM. It is important to note, however, 
that we have not ruled out the possibility 
that phosphorylation of the receptor 
quantitatively alters its affinity for insulin. 
Quantification of the alteration (if any) 
in the affinity of the receptor for insulin 
caused by phosphorylation will probably 
require studies with pure, intact receptor. 
New purification protocols must be devel- 
oped, however, to obtain pure intact re- 
ceptor kinase, since the published affinity 
chromatography procedures (e.g. (25)) 
yield preparations wherein the active in- 
tact receptor kinase is grossly contami- 
nated by enzymatically inactive, low-mo- 
lecular-weight forms of the receptor. 
Receptor crosslinked in the presence of 
100 nM insulin and 50 pM [T-~‘P]ATP was 
reduced and subjected to SDS-PAGE to 
determine the accessibility of the (Y-(Y, /3- 
8, and a-8 subunit interfaces to the cross- 
linking agent DSS. The autoradiograms 
in Fig. 5 indicate that reduction of the 
major 32P-containing band at 340 kDa 
(lane 1) results in the formation of three 
bands with electrophoretic mobilities cor- 
responding to 95, 190, and 380 kDa. The 
most plausible explanation of this obser- 
vation is that the 95-kDa band represents 
phosphorylated /3 subunits which were 
not crosslinked to other subunits, and 
that the other 32P-containing bands reflect 
crosslinking of the @ chain to other chains 
(see below). 
Figure 6 depicts the effect of reduction 
(with DTT) of receptor which was cross- 
linked in the presence of ‘ZI-insulin. Lane 
1 of Fig. 6A shows the three major insulin 
binding forms at 290, 320, and 340 kDa 
obtained upon crosslinking the receptor 
without subsequent treatment with re- 




FIG. 5. Subunit composition of crosslinked phos- 
phorylated receptor. After 1 h preincubation with 
100 nM insulin, the receptor (10 pg in 100 ~1) was 
phosphorylated with 50 PM [T-~JATP for 5 min, 
crosslinked with 0.3 mM DSS, and denatured by 
heating the sample for 3 min with sample buffer 
without (1) and with (2) 25 mM DTT. Sample (3) 
was the gel band of the 340~kDa phosphorylated 
receptor which was excised from a previous gel and 
treated with sample buffer containing 25 mM DTT. 
With molecular weight markers (myosin, p-galacto- 
sidase, and phosphorylase 5) for calibration, the 
three major bands in (3) were estimated to be, from 
the top, 380, 190, and 95 kDa. 
ducing agent. Lane 2 shows the ability of 
unlabeled insulin to diminish this labeling 
pattern, and demonstrates the specificity 
of the affinity crosslinking procedure. 
Lanes 3, 4, and 5 demonstrate the effect 
of treatment with increasing concentra- 
tions of DTT on the electrophoretic pat- 
tern of the radioactive bands. Interest- 
ingly, reduction gives rise primarily to 
two bands with apparent M;s of 125 and 
240 kDa. Figure 6B, wherein bands cor- 
responding to 290, 320, and 340 kDa were 
excised from the gel and separately re- 
duced, shows that each species gives rise 
to the 125- and 240-kDa species. Close 
examination of the autoradiograms in 
lanes 6, 7, and 8 reveals that reduction of 
each of the bands in lanes 3, 4, and 5 
gives rise to small amounts of species 
which migrate as if they had molecular 
weights about 40 kDa higher than the 
parent bands. These bands of increased 
molecular weight, and the 380~kDa band 
produced upon reduction of the 340-kDa 
crosslinked receptor labeled with %P (Fig. 
5), are attributed to receptor which was 
crosslinked to such an extent that reduc- 
tion of interchain disulfide bonds did not 
result in dissociation of the subunits com- 
prising the receptor. The increase in ap- 
parent M, is attributed to partial unfold- 
ing of crosslinked receptor upon reduction 
of the disulfide bands with DTT.” 
The 125-kDa band is attributed to (Y 
chains which were not crosslinked to other 
polypeptide chains. The 240-kDa band 
cannot be attributed to a crosslinked a/3 
dimer, since a band having the same ap- 
parent molecular weight should have been 
observed when crosslinked receptor la- 
beled with [32P]phosphate was reduced. 
Thus it is reasonable to attribute the 240- 
kDa band to a crosslinked LY dimer, and 
to attribute the 190-kDa band observed 
with receptor labeled with $Plphosphate 
to a crosslinked fi dimer. Our observation 
of a small amount of receptor tetramer 
that cannot be dissociated with even 25 
mM DTT in the presence of SDS strongly 
suggests that the crosslinking agent DSS 
can crosslink the c.rfl interface. Crosslink- 
ing at the ~$3 interface, however, is prob- 
ably markedly slower than crosslinking 
at either the CMY or /3j3 subunit interface, 
as evidenced by the failure to accumulate 
detectable levels of crosslinked a/3 dimer. 
The reactivity of the QLY and &3 subunit 
interfaces of the receptor suggests that a 
substantial segment of these subunit in- 
terfaces contain hydrophilic amino groups 
’ Crosslinks present in the tetramer may cause it 
to resist complete unfolding. Thus, the discrepancy 
between the apparent molecular mass of 330 kDa 
observed for the intact tetramer and the value of 
440 kDa expected from the mass of two (Y and two 
fl chains may reflect an anomalously high electro- 
phoretic mobility of a partially unfolded protein. 
Experimental error and the uncertainty associated 
with estimates of the mass of glycoproteins from 
their electrophoretic mobilities could also contribute 
to the discrepancy. 
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FIG. 6. Subunit composition of insulin receptor crosslinked with ‘l-insulin. (A) Insulin receptor 
(10 pg in 200 ~1) was incubated with 6 nM ‘“I-insulin in 25 mM Hepes, pH 7.6, 0.1 M NaCl, 0.1% 
BSA, 0.05% Triton, without (1) and with (2) 0.5 PM insulin, at 4°C for 16 h. The samples were 
crosslinked with 0.3 mrd DSS at 0% for 45 min, and were denatured by heating in nonreducing 
sample buffer. Sample (1) was also treated with increasing concentrations of DTT: 25 (3), 50 (4), 
and 75 mM (5). The samples were run in a 4.5% gel. These high concentrations of DTT were used 
to exclude the possibility that the band which migrated in the range of 240 kDa, after treatment 
with lower concentrations of DTT, was due to incompletely reduced material. (B) Sample (1) and 
(2) were identical to (A), but in a separate gel. Samples (3, 6), (4, ‘7), and (5, 8) were the excised 
gel bands from (A) with &f,‘s of 290, 3Xl, and 340 kDa, respectively. Samples 6-8 were treated 
with 25 mM DTT, whereas 3-5 were not. High-molecular-weight bands, (barely detectable in this 
exposure) in 6, 7, and 8 were estimated to be 320, 340, and 380 kDa, respectively. Samples 1-8 
were run in the same gel, but samples 3-8 were autoradiographed longer in order to show the 
radioactive bands in 6-8. The marked reduction in the intensity of the bands upon reduction is 
consistent with the view that the insulin is primarily labeled with =I in the A chain whereas 
the B chain is primarily crosslinked to the receptor. Although the autoradiograms depicted in 
(A) were obt.ained in presence of 6 n?d ‘l-insulin and no ATP, the bands attributed to a monomer 
(125 kDa) and (Y dimer (240 kDa) were also obtained when the insulin receptor was crosslinked 
under phosphorylation conditions (in the presence of ATP and Mn+* and higher concentrations of 
‘%I-insulin) similar to those used for the experiments described in Fig. 5. Under these conditions 
as well as in the absence of ATP, no band which could be attributed to aB dimer was observed. 
In Fig. 6 a low concentration of high-specific-activity ‘l-insulin was used to maximize receptor 
labeling so that the subunit composition of each of the insulin binding forms could be examined 
individually. 
which are accessible to the crosslinking that reduction of each of the 340-, 320-, 
agent. and 290-kDa forms of the crosslinked re- 
Our observation that reduction of affin- ceptor yields a mixture of (Y dimer and a! 
ity crosslinked receptor yields LY dimer monomer is consistent with the conclusion 
and p dimer indicates that the intact that the heterogeneity of the receptor is 
receptor must contain two (Y and two /3 due primarily to limited proteolysis of the 
chains, and provides strong support for /3 chain (24). This finding also rules out 
the symmetrical, tetrameric, cll&& model (at least for insulin receptor from human 
which has been proposed for the structure placenta) an alternative model proposed 
of insulin receptors (1,4, 26). The finding for the structure of the receptor, wherein 
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the major form of insulin receptor was 
envisaged as containing one 130-kDa, one 
90-kDa, and two IO-kDa polypeptides (27). 
The failure of the 320-kDa putative 
c&I& tetramer to undergo autophosphor- 
ylation indicates that receptor autophos- 
phorylation requires two intact /3 chains. 
This result suggests that, in the tetrameric 
receptor, phosphorylation might be an 
interchain process wherein one /II chain, 
acting as a kinase, phosphorylates the 
other /3 chain, and the limited proteolysis 
of the j3 chain which results in the for- 
mation of & abolishes its competence to 
act as a kinase or kinase substrate. It is 
important to note, however, that partially 
reduced receptor has been observed by 
Shia et al. (28) to yield phosphorylated c@ 
dimers upon treatment with ATP and 
insulin followed by SDS-PAGE. Since it 
is not clear whether the ~$3 dimers dis- 
sociated from the reduced tetrameric re- 
ceptor prior to phosphorylation and prior 
to addition of SDS, it is difficult to con- 
clude from this observation whether iso- 
lated @3 dimers are competent to under- 
go autophosphorylation. The competence 
of isolated c@ dimers to undergo unimo- 
lecular autophosphorylation would, of 
course, exclude the possibility that auto- 
phosphorylation requires interaction be- 
tween the two @ chains. 
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